Latest news
What Vir Biotechnology (VIR)'s Profit Swing But Earnings Miss Means For Shareholders - simplywall.stsimplywall.st · Sat, 08 Aug 2026 07:48:21 GMTVir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:18:56 GMTVir Biotechnology (VIR): State Street discloses 9.96M-share, 5.9% ownership position - Stock TitanStock Titan · Fri, 07 Aug 2026 15:11:21 GMTUnderstanding Momentum Shifts in (VIR) - Stock Traders DailyStock Traders Daily · Fri, 07 Aug 2026 14:50:01 GMTA Quick Look at Today's Ratings for Vir Biotechnology(VIR.US), With a Forecast Between $18 to $30 - news.futunn.comnews.futunn.com · Thu, 06 Aug 2026 13:00:02 GMTVir Biotechnology (VIR) Could Be 58% Below Fair Value On Q2 Profit Turnaround - simplywall.stsimplywall.st · Thu, 06 Aug 2026 12:56:04 GMTVir Biotechnology, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:30:00 GMTVIR Looks 63.2% Undervalued on GF Value™ - GuruFocusGuruFocus · Thu, 06 Aug 2026 10:22:03 GMT